330 filings
Page 2 of 17
8-K
a7e1w9 pmvi
3 Jul 23
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
6:06am
PX14A6G
g9dhtqw
1 Jun 23
Letter to shareholders
2:01pm
S-8
pdwabgfmnfyz
26 May 23
Registration of securities for employees
4:39pm
8-K
tpeajdck36d2j 61z2tx
17 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
PX14A6G
svp l3x4mdfsg2xi43bi
17 May 23
Letter to shareholders
4:00pm
PX14A6G
jrab25db
11 May 23
Letter to shareholders
11:34am
DEFA14A
5d2w7ar6c31mm2zv
8 May 23
Additional proxy soliciting materials
4:04pm
PX14A6G
eogvtr7
5 May 23
Letter to shareholders
11:17am
8-K
7awm3
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
PX14A6G
qqi0w
3 May 23
Letter to shareholders
2:53pm
DEFA14A
2vvlt 6iv6x
2 May 23
Additional proxy soliciting materials
4:39pm
DEFA14A
iyaalshbfbbbhc
28 Apr 23
Additional proxy soliciting materials
4:03pm
PX14A6G
iymqsh0lp0
26 Apr 23
Letter to shareholders
10:20am
8-K
8q6jz1w n97v65
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
8-K
7h2vj9 is
13 Mar 23
Other Events
6:03am
8-K
0qxs3084b2 20
28 Feb 23
Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates
6:03am
8-K
w6df9002zaztzt
27 Jan 23
Other Events
4:07pm